Annual Total Expenses
$456.38 M
+$51.64 M+12.76%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual total expenses is $456.38 million, with the most recent change of +$51.64 million (+12.76%) on December 31, 2023.
- During the last 3 years, RVNC annual total expenses has risen by +$167.89 million (+58.20%).
- RVNC annual total expenses is now at all-time high.
Performance
RVNC Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$92.14 M
-$7.77 M-7.78%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly total expenses is $92.14 million, with the most recent change of -$7.77 million (-7.78%) on September 30, 2024.
- Over the past year, RVNC quarterly total expenses has increased by +$461.00 thousand (+0.50%).
- RVNC quarterly total expenses is now -42.94% below its all-time high of $161.46 million, reached on December 31, 2023.
Performance
RVNC Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
RVNC Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.8% | +0.5% |
| 3 y3 years | +58.2% | -0.4% |
| 5 y5 years | +211.8% | +116.3% |
RVNC Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +29.5% | -42.9% | +6.9% |
| 5 y | 5-year | at high | +176.8% | -42.9% | +99.2% |
| alltime | all time | at high | +1512.9% | -42.9% | +993.5% |
Revance Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $92.14 M(-7.8%) |
| Jun 2024 | - | $99.91 M(+1.2%) |
| Mar 2024 | - | $98.76 M(-38.8%) |
| Dec 2023 | $456.38 M(+12.8%) | $161.46 M(+76.1%) |
| Sep 2023 | - | $91.67 M(-17.2%) |
| Jun 2023 | - | $110.76 M(+19.8%) |
| Mar 2023 | - | $92.48 M(-25.7%) |
| Dec 2022 | $404.73 M(+14.8%) | $124.54 M(+16.9%) |
| Sep 2022 | - | $106.50 M(+23.5%) |
| Jun 2022 | - | $86.21 M(-1.5%) |
| Mar 2022 | - | $87.48 M(-0.1%) |
| Dec 2021 | $352.47 M(+22.2%) | $87.55 M(-5.3%) |
| Sep 2021 | - | $92.47 M(+3.7%) |
| Jun 2021 | - | $89.14 M(+7.0%) |
| Mar 2021 | - | $83.31 M(-6.5%) |
| Dec 2020 | $288.49 M(+75.0%) | $89.10 M(+10.1%) |
| Sep 2020 | - | $80.96 M(+41.0%) |
| Jun 2020 | - | $57.40 M(-5.9%) |
| Mar 2020 | - | $61.02 M(+31.9%) |
| Dec 2019 | $164.87 M(+12.6%) | $46.26 M(+8.6%) |
| Sep 2019 | - | $42.59 M(+8.9%) |
| Jun 2019 | - | $39.12 M(+6.0%) |
| Mar 2019 | - | $36.91 M(-5.1%) |
| Dec 2018 | $146.36 M | $38.89 M(+8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $36.00 M(+1.1%) |
| Jun 2018 | - | $35.60 M(-0.7%) |
| Mar 2018 | - | $35.85 M(+9.0%) |
| Dec 2017 | $117.76 M(+48.2%) | $32.89 M(+6.8%) |
| Sep 2017 | - | $30.79 M(+14.4%) |
| Jun 2017 | - | $26.92 M(-0.9%) |
| Mar 2017 | - | $27.16 M(+38.4%) |
| Dec 2016 | $79.46 M(+9.4%) | $19.63 M(+10.3%) |
| Sep 2016 | - | $17.80 M(-19.9%) |
| Jun 2016 | - | $22.21 M(+12.1%) |
| Mar 2016 | - | $19.82 M(-9.3%) |
| Dec 2015 | $72.62 M(+38.5%) | $21.86 M(+16.0%) |
| Sep 2015 | - | $18.84 M(+13.1%) |
| Jun 2015 | - | $16.66 M(+9.3%) |
| Mar 2015 | - | $15.25 M(+9.5%) |
| Dec 2014 | $52.43 M(+35.0%) | $13.92 M(+0.2%) |
| Sep 2014 | - | $13.90 M(+7.2%) |
| Jun 2014 | - | $12.97 M(+11.4%) |
| Mar 2014 | - | $11.64 M(+26.0%) |
| Dec 2013 | $38.84 M(-11.5%) | $9.24 M(+9.7%) |
| Sep 2013 | - | $8.43 M(-26.2%) |
| Jun 2013 | - | $11.42 M(+17.1%) |
| Mar 2013 | - | $9.75 M(-47.3%) |
| Dec 2012 | $43.90 M(+55.2%) | $18.49 M |
| Dec 2011 | $28.30 M | - |
FAQ
- What is Revance Therapeutics annual total expenses?
- What is the all time high annual total expenses for Revance Therapeutics?
- What is Revance Therapeutics annual total expenses year-on-year change?
- What is Revance Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Revance Therapeutics?
- What is Revance Therapeutics quarterly total expenses year-on-year change?
What is Revance Therapeutics annual total expenses?
The current annual total expenses of RVNC is $456.38 M
What is the all time high annual total expenses for Revance Therapeutics?
Revance Therapeutics all-time high annual total expenses is $456.38 M
What is Revance Therapeutics annual total expenses year-on-year change?
Over the past year, RVNC annual total expenses has changed by +$51.64 M (+12.76%)
What is Revance Therapeutics quarterly total expenses?
The current quarterly total expenses of RVNC is $92.14 M
What is the all time high quarterly total expenses for Revance Therapeutics?
Revance Therapeutics all-time high quarterly total expenses is $161.46 M
What is Revance Therapeutics quarterly total expenses year-on-year change?
Over the past year, RVNC quarterly total expenses has changed by +$461.00 K (+0.50%)